CERo Therapeutics Holdings, Inc. (NASDAQ:CERO – Get Free Report) major shareholder Stuart M. Sloan sold 532,486 shares of the company’s stock in a transaction on Wednesday, September 25th. The stock was sold at an average price of $0.10, for a total value of $53,248.60. Following the sale, the insider now owns 21,067,956 shares of the company’s stock, valued at approximately $2,106,795.60. The trade was a 2.47 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
CERo Therapeutics Price Performance
CERO stock opened at $0.25 on Thursday. The stock has a 50-day moving average price of $0.11 and a two-hundred day moving average price of $0.33. CERo Therapeutics Holdings, Inc. has a 12-month low of $0.06 and a 12-month high of $12.80.
About CERo Therapeutics
Further Reading
- Five stocks we like better than CERo Therapeutics
- The Basics of Support and Resistance
- NVIDIA Growth Slows: So What? The Uptrend Will Continue
- Using the MarketBeat Stock Split Calculator
- Medtronic: A Dividend Aristocrat Powering Up for 2025 and Beyond
- Consumer Discretionary Stocks Explained
- Robinhood’s 330% Surge: Sustainable Rally or Bull Market Mirage?
Receive News & Ratings for CERo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CERo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.